These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34788006)

  • 1. Visible Light and Glutathione Dually Responsive Delivery of a Polymer-Conjugated Temozolomide Intermediate for Glioblastoma Chemotherapy.
    Du K; Xia Q; Sun J; Feng F
    ACS Appl Mater Interfaces; 2021 Dec; 13(47):55851-55861. PubMed ID: 34788006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymer-Drug Conjugates Codeliver a Temozolomide Intermediate and Nitric Oxide for Enhanced Chemotherapy against Glioblastoma Multiforme.
    Du K; Li X; Feng F
    ACS Appl Bio Mater; 2024 Mar; 7(3):1810-1819. PubMed ID: 38403964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced Copper-Temozolomide Interactions by Protein for Chemotherapy against Glioblastoma Multiforme.
    Li X; Shao F; Sun J; Du K; Sun Y; Feng F
    ACS Appl Mater Interfaces; 2019 Nov; 11(45):41935-41945. PubMed ID: 31644262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temozolomide-Doxorubicin Conjugate as a Double Intercalating Agent and Delivery by Apoferritin for Glioblastoma Chemotherapy.
    Du K; Xia Q; Heng H; Feng F
    ACS Appl Mater Interfaces; 2020 Aug; 12(31):34599-34609. PubMed ID: 32648735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomimetic Polymer-Templated Copper Nanoparticles Stabilize a Temozolomide Intermediate for Chemotherapy against Glioblastoma Multiforme.
    Wang X; Hu A; Du K; Feng F
    ACS Appl Bio Mater; 2021 Nov; 4(11):8004-8012. PubMed ID: 35006781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a PAMAM Dendrimer for Sustained Release of Temozolomide against Experimental Murine Lymphoma: Assessment of Therapeutic Efficacy.
    Sk UH; Hira SK; Rej A; RoyMahapatra D; Manna PP
    ACS Appl Bio Mater; 2021 Mar; 4(3):2628-2638. PubMed ID: 35014379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temozolomide Efficacy and Metabolism: The Implicit Relevance of Nanoscale Delivery Systems.
    Petrenko D; Chubarev V; Syzrantsev N; Ismail N; Merkulov V; Sologova S; Grigorevskikh E; Smolyarchuk E; Alyautdin R
    Molecules; 2022 May; 27(11):. PubMed ID: 35684445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced Anti-Tumor Activity in Mice with Temozolomide-Resistant Human Glioblastoma Cell Line-Derived Xenograft Using SN-38-Incorporated Polymeric Microparticle.
    Yang TC; Liu SJ; Lo WL; Chen SM; Tang YL; Tseng YY
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34074038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel structural-related analogs of PFI-3 (SRAPs) that target the BRG1 catalytic subunit of the SWI/SNF complex increase the activity of temozolomide in glioblastoma cells.
    He Y; Yang C; Wang Y; Sacher JR; Sims MM; Pfeffer LM; Miller DD
    Bioorg Med Chem; 2022 Jan; 53():116533. PubMed ID: 34863065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of Temozolomide and N3-Propargyl Analog to Brain Tumors Using an Apoferritin Nanocage.
    Bouzinab K; Summers HS; Stevens MFG; Moody CJ; Thomas NR; Gershkovich P; Weston N; Ashford MB; Bradshaw TD; Turyanska L
    ACS Appl Mater Interfaces; 2020 Mar; 12(11):12609-12617. PubMed ID: 32073826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of GSH synthesis potentiates temozolomide-induced bystander effect in glioblastoma.
    Kohsaka S; Takahashi K; Wang L; Tanino M; Kimura T; Nishihara H; Tanaka S
    Cancer Lett; 2013 Apr; 331(1):68-75. PubMed ID: 23246370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-catenin contributes to cordycepin-induced MGMT inhibition and reduction of temozolomide resistance in glioma cells by increasing intracellular reactive oxygen species.
    Bi Y; Li H; Yi D; Bai Y; Zhong S; Liu Q; Chen Y; Zhao G
    Cancer Lett; 2018 Oct; 435():66-79. PubMed ID: 30081068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
    Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
    Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-targeted delivery of temozolomide by multi-responsive nanoplatform via tumor microenvironment modulation for overcoming drug resistance to treat glioblastoma.
    Chen X; Zheng Y; Zhang Q; Chen Q; Chen Z; Wu D
    J Nanobiotechnology; 2024 May; 22(1):264. PubMed ID: 38760771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymer-Temozolomide Conjugates as Therapeutics for Treating Glioblastoma.
    Ward SM; Skinner M; Saha B; Emrick T
    Mol Pharm; 2018 Nov; 15(11):5263-5276. PubMed ID: 30354145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists.
    Liu Z; Jiang X; Gao L; Liu X; Li J; Huang X; Zeng T
    World Neurosurg; 2019 Aug; 128():e468-e477. PubMed ID: 31048057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
    Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J
    Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic anticancer effect of acteoside and temozolomide-based glioblastoma chemotherapy.
    Hwang TW; Kim DH; Kim DB; Jang TW; Kim GH; Moon M; Yoon KA; Choi DE; Park JH; Kim JJ
    Int J Mol Med; 2019 Mar; 43(3):1478-1486. PubMed ID: 30664150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of transferrin-targeted temozolomide nano-micelles and their anti-glioma effect.
    Yu J; Xue Y
    PeerJ; 2024; 12():e17979. PubMed ID: 39285923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-Targeted Novel Temozolomide Nanocapsules Encapsulating siPKM2 Inhibit Aerobic Glycolysis to Sensitize Glioblastoma to Chemotherapy.
    Zhang Y; Ma H; Li L; Sun C; Yu C; Wang L; Xu D; Song X; Yu R
    Adv Mater; 2024 Jul; 36(29):e2400502. PubMed ID: 38651254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.